BioSpace News Archive

Scientists at the University of Cambridge have identified mechanisms by which drug sensitivities characteristic of ATM-deficient cells can be counteracted by changes in other genes.

Ascension Healthcare plc (“Ascension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for haemophilia and osteoarthritis is pleased to announce the appointment of Dr Gavin Ling as Chief Medical Officer.

The world’s deadliest major cancer – pancreatic cancer – still has a five-year survival rate of just 9 percent, according to the Cancer Facts & Figures report released today by the American Cancer Society (ACS), and it is projected to become the second leading cause of cancer-related death in the United States as early as next year.

Fueling unique lifestyles with functional foods to help students live better lives

Move positions company to bring a new standard of care to U.S. hospitals in effort to improve cardiac arrest outcomes

Centene Corporation today issued a reminder that it will release its 2018 fourth quarter and full year financial results at approximately 6 a.m. (Eastern Time) on Tuesday, February 5, 2019, and host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results.

CHADD and Russell A. Barkley, Ph.D., Partner to Announce Findings

Funding marks the beginning of a relationship aligned around behavioral health innovation

NEW OPTION FOR LICENSED NURSES

The Board of Directors of the Center for Medical Technology Policy (CMTP ) announced today that its current President, Donna Messner , PhD, will become CMTP’s new Chief Executive Officer, effective February 1 , 2019.